Mannkind (MNKD) Research & Development (2010 - 2026)
Mannkind (MNKD) reported Research & Development of $17.2 million for Q1 2026, up 56.33% year-over-year from $11.0 million in Q1 2025, and down 37.54% on a QoQ basis from $27.6 million in Q4 2025.
Mannkind (MNKD) has 17 years of Research & Development data on file, last reported at $17.2 million in Q1 2026.
- Quarterly Research & Development rose 56.33% year-over-year to $17.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $72.6 million (up 54.7% YoY) and the FY2025 annual result came in at $66.3 million, up 44.57% from the prior year.
- Research & Development slipped to $17.2 million in Q1 2026 per MNKD's latest filing, from $27.6 million in the prior quarter.
- Across five years, Research & Development topped out at $27.6 million in Q4 2025 and bottomed at $3.5 million in Q1 2022.
- The 5-year median for Research & Development is $10.0 million (2024), against an average of $10.6 million.
- Peak annual rise in Research & Development reached 147.69% in 2025, while the deepest fall reached 8.8% in 2025.
- Tracing MNKD's Research & Development over 5 years: stood at $7.2 million in 2022, then advanced by 29.07% to $9.2 million in 2023, then climbed by 20.59% to $11.1 million in 2024, then soared by 147.69% to $27.6 million in 2025, then tumbled by 37.54% to $17.2 million in 2026.
- Per Business Quant, the three latest MNKD Research & Development figures stand at $17.2 million (Q1 2026), $27.6 million (Q4 2025), and $14.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 626,092.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 4.32 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -101.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 1.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 961.60 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -2.30 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.54 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 364.87 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 17.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.23 Mn |
| Dec 31, 2025 | 27.59 Mn |
| Sep 30, 2025 | 14.06 Mn |
| Jun 30, 2025 | 13.68 Mn |
| Mar 31, 2025 | 11.02 Mn |
| Dec 31, 2024 | 11.14 Mn |
| Sep 30, 2024 | 12.93 Mn |
| Jun 30, 2024 | 11.82 Mn |
| Mar 31, 2024 | 10.01 Mn |
| Dec 31, 2023 | 9.24 Mn |
| Sep 30, 2023 | 9.99 Mn |
| Jun 30, 2023 | 6.45 Mn |
| Mar 31, 2023 | 5.61 Mn |
| Dec 31, 2022 | 7.16 Mn |
| Sep 30, 2022 | 4.14 Mn |
| Jun 30, 2022 | 4.89 Mn |
| Mar 31, 2022 | 3.54 Mn |
| Dec 31, 2021 | 3.89 Mn |
| Sep 30, 2021 | 3.66 Mn |
| Jun 30, 2021 | 2.33 Mn |
| Mar 31, 2021 | 2.44 Mn |
| Dec 31, 2020 | 1.55 Mn |
| Sep 30, 2020 | 1.48 Mn |
| Jun 30, 2020 | 1.46 Mn |
| Mar 31, 2020 | 1.76 Mn |
| Dec 31, 2019 | 2.02 Mn |
| Sep 30, 2019 | 1.58 Mn |
| Jun 30, 2019 | 1.63 Mn |
| Mar 31, 2019 | 1.67 Mn |
| Dec 31, 2018 | 1.08 Mn |
| Sep 30, 2018 | 2.04 Mn |
| Jun 30, 2018 | 2.97 Mn |
| Mar 31, 2018 | 2.64 Mn |
| Dec 31, 2017 | 3.51 Mn |
| Sep 30, 2017 | 4.36 Mn |
| Jun 30, 2017 | 3.12 Mn |
| Mar 31, 2017 | 3.13 Mn |
| Dec 31, 2016 | 1.56 Mn |
| Sep 30, 2016 | 3.92 Mn |
| Jun 30, 2016 | 4.31 Mn |
| Mar 31, 2016 | 5.13 Mn |
| Dec 31, 2015 | 6.22 Mn |
| Sep 30, 2015 | 6.34 Mn |
| Jun 30, 2015 | 7.74 Mn |
| Mar 31, 2015 | 9.38 Mn |
| Dec 31, 2014 | 17.56 Mn |
| Sep 30, 2014 | 19.18 Mn |
| Jun 30, 2014 | 37.32 Mn |
| Mar 31, 2014 | 26.18 Mn |
| Dec 31, 2013 | 28.99 Mn |
| Sep 30, 2013 | 27.28 Mn |
| Jun 30, 2013 | 27.05 Mn |
| Mar 31, 2013 | 26.40 Mn |
| Dec 31, 2012 | 25.28 Mn |
| Sep 30, 2012 | 25.45 Mn |
| Jun 30, 2012 | 26.64 Mn |
| Mar 31, 2012 | 24.16 Mn |
| Dec 31, 2011 | 20.24 Mn |
| Sep 30, 2011 | 23.13 Mn |
| Jun 30, 2011 | 30.30 Mn |
| Mar 31, 2011 | 26.29 Mn |
| Dec 31, 2010 | 24.22 Mn |
| Sep 30, 2010 | 31.41 Mn |
| Jun 30, 2010 | 26.16 Mn |